Skip to content
2000
Volume 19, Issue 12
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Pathogenic free-living amoeba are known to cause a devastating infection of the central nervous system and are often referred to as “brain-eating amoebae”. The mortality rate of more than 90% and free-living nature of these amoebae is a cause for concern. It is distressing that the mortality rate has remained the same over the past few decades, highlighting the lack of interest by the pharmaceutical industry. With the threat of global warming and increased outdoor activities of public, there is a need for renewed interest in identifying potential anti-amoebic compounds for successful prognosis. Here, we discuss the available chemotherapeutic options and opportunities for potential strategies in the treatment and diagnosis of these life-threatening infections.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557519666190313161854
2019-07-01
2025-07-10
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557519666190313161854
Loading

  • Article Type:
    Review Article
Keyword(s): Acanthamoeba; Balamuthia; Brain-eating amoebae; drugs; in vitro; Naegleria; survival
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test